Affimed N.V. (AFMD) SEC Filing 20-F Annual report for the fiscal year ending Wednesday, December 31, 2014

Affimed N.V.

CIK: 1608390 Ticker: AFMD

View differences made from one year to another to evaluate Affimed N.V.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Affimed N.V..


Assess how Affimed N.V.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Affimed N.V.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2015 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: AFMD
CIK: 1608390
Form Type: 20-F Annual Report
Accession Number: 0000950103-15-002323
Submitted to the SEC: Wed Mar 25 2015 7:38:38 AM EST
Accepted by the SEC: Wed Mar 25 2015
Period: Wednesday, December 31, 2014
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: